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Abstract
Background: A positive family history of chronic diseases including cancer can be used as an index of
genetic and shared environmental influences. The tumours studied have several putative risk factors in
common including occupational exposure to certain pesticides and a positive family history of cancer.
Methods: We conducted population-based studies of Hodgkin lymphoma (HL), Multiple Myeloma (MM),
non-Hodgkin's Lymphoma (NHL), and Soft Tissue Sarcoma (STS) among male incident case and control
subjects in six Canadian provinces. The postal questionnaire was used to collect personal demographic
data, a medical history, a lifetime occupational history, smoking pattern, and the information on family
history of cancer. The family history of cancer was restricted to first degree relatives and included
relationship to the index subjects and the types of tumours diagnosed among relatives. The information
was collected on 1528 cases (HL (n = 316), MM (n = 342), NHL (n = 513), STS (n = 357)) and 1506 age ±
2 years and province of residence matched control subjects. Conditional logistic regression analyses
adjusted for the matching variables were conducted.
Results: We found that most families were cancer free, and a minority included two or more affected
relatives. HL [(ORadj (95% CI) 1.79 (1.33, 2.42)], MM (1.38(1.07, 1.78)), NHL (1.43 (1.15, 1.77)), and
STS cases (1.30(1.00, 1.68)) had higher incidence of cancer if any first degree relative was affected with
cancer compared to control families. Constructing mutually exclusive categories combining "family history
of cancer" (yes, no) and "pesticide exposure ≥10 hours per year" (yes, no) indicated that a positive family
history was important for HL (2.25(1.61, 3.15)), and for the combination of the two exposures increased
risk for MM (1.69(1.14,2.51)). Also, a positive family history of cancer both with (1.72 (1.21, 2.45))
and without pesticide exposure (1.43(1.12, 1.83)) increased risk of NHL.
Conclusion: HL, MM, NHL, and STS cases had higher incidence of cancer if any first degree relative
affected with cancer compared to control families. A positive family history of cancer and/or shared
environmental exposure to agricultural chemicals play an important role in the development of cancer.
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Background
At the cellular level, all cancers are genetic [1]. A positive
family history of chronic diseases including cancer can be
used as an index of genetic and shared environmental
influences [2,3]. The four types of tumours under investi-
gation (Hodgkin Lymphoma, Multiple Myeloma, Non-
Hodgkin's Lymphoma and Soft Tissue Sarcoma) have sev-
eral putative risk factors [4-63] in common, which include
occupational exposure to certain chemicals and specific
pesticides [4-37], a positive family history of cancer specif-
ically of the hematopoietic system [29,30,37-54], a posi-
tive personal history of cancer or other diseases, as well as
certain types of medical treatments for cancer and per-
sonal habits [38,55-63].
Researchers have stated that more than 80% of human
cancers can be attributed to environmental factors
[2,3,64,65]. Inherited and shared environmental influ-
ences among family members (such as tobacco smoke,
viruses, agricultural chemicals and dusts, animal contact)
that contribute to cancer's development can sometimes be
delineated by (a) deconstructing the familial pattern of
tumour occurrences (parent-offspring versus sibling-sib-
ling), and (b) collecting detailed information of historical
exposure by utilizing various methods. Simultaneously,
in order to compare the family history of cancer, we con-
ducted population-based case-control studies of Hodgkin
Lymphoma, Multiple Myeloma, Non-Hodgkin's Lym-
phoma and Soft Tissue Sarcoma among male incident
case and control subjects in six Canadian provinces using
postal questionnaires in order to compare details of fam-
ily history of cancer among them.
Methods
The detailed methodology has been previously published
[38]. Briefly, we contacted male incident cases aged 19
years or older with a first diagnosis of Hodgkin Lym-
phoma (ICD-9 201), Multiple Myeloma (ICD-9 203),
Non-Hodgkin's Lymphoma (ICD-9 200 or 202), Soft Tis-
sue Sarcoma (ICD-9 code 171 and any other ICD-9 cate-
gory with certain specified morphology codes), who were
diagnosed on or after September 1st, 1991 until at the lat-
est on or before December 31st, 1994, and who were resi-
dents of six Canadian provinces (Quebec, Ontario,
Manitoba, Saskatchewan, Alberta, and British Columbia).
The Cases were ascertained from provincial cancer regis-
tries except in Quebec where hospital registries were used.
The control subjects were males aged 19 years and older
selected from provincial Health Insurance records
(Alberta, Saskatchewan, Manitoba, and Quebec), tele-
phone listings (Ontario) or Voter's lists (British Colum-
bia). The random control subject selection was stratified
by age ± 2 years to be comparable to the age distribution
of the entire case group within each province.
The family history section of the postal questionnaire
used in this study was developed and validated by
McDuffie  et al [66]. The family history section was
designed to collect information on the number and sex of
siblings and children of the index subjects. Additional
queries ascertained information on the index subject's
children who were either stillborn, born with a genetic
disease and/or a birth defect. The definition of family was
restricted to first degree relatives; parents, siblings and
children. Within each family there were three generations:
parents, sibling and children. Half-siblings, adopted sib-
lings or children and stepchildren were excluded. Both liv-
ing and deceased first degree relatives were included. The
information on family history of cancer included the
affected individual's relationship of to the index subject,
the site of the cancer, and the year and province of diag-
nosis. Reported cancer in family members was not veri-
fied.
The questionnaire instrument was also used to collect per-
sonal demographic data, health history, smoking pattern
and lifetime occupational history. Exposure to broad
classes of pesticides (herbicides, insecticides, fumigants,
fungicides, and algaecides) was included as these were
potential confounders of the putative association between
a positive family history of cancer and each of the tumours
of interest. Pesticide exposure was a calculated variable
that required affirmative responses to questions concern-
ing exposure to any combination of the pesticides listed.
Cumulative exposure of ten hours per year or more to pes-
ticides was considered a positive response.
Data Management and Statistical Analysis
The questionnaires were reviewed for completeness and
consistency of the responses by the coordinators in each
province. The data were computer coded in the province
of origin using SPSS-DE [67]; they were also checked and
transported on disks to the coordinating centre where the
data were reviewed for completeness and internal consist-
ency. The analytic approach was that suggested by Breslow
et al [68]. We used SAS [69] computer software to conduct
the analyses.
We conducted descriptive statistical analyses and com-
pared family history of cancer among each case group to
the control group's family history data. In addition four
mutually exclusive categories combining the variables
family history of cancer (yes, no) and pesticide exposure
≥10 hours/year (yes, no) were constructed. Similar mutu-
ally exclusive categories were formed for family history of
cancer and smoking status (non-smokers, ex-smoker or
current smoker). We conducted conditional logistic
regression analyses adjusted for the matching variablesBMC Cancer 2009, 9:70 http://www.biomedcentral.com/1471-2407/9/70
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age and province of residence. We report adjusted odds
ratios (ORadj) and 95% confidence intervals (95% CI).
Ethical Approval
The letters of informed consent, the questionnaires and
other written material provided to potential subjects were
submitted to and approved by each of the relevant agen-
cies in each province. For Saskatchewan, the University of
Saskatchewan Biomedical Research Ethics Board (#89-
12); for British Columbia, the University of British
Columbia Behavioural Research Ethics Board (#B91-
185); for Quebec, the University of McGill Human Ethics
Board; for Alberta, the University of Alberta Health
Research Ethics Board (Biomedical Panel); for Manitoba,
the University of Manitoba Biomedical Research Ethics
Board; and for Ontario, the University of Toronto Health
Sciences Research Board approved the study protocol. All
information that could be used to identify the individuals
remained within the province of origin under the control
of each province's principal investigator. After receiving
permission to contact a potential case by the attending
physician, a letter of informed consent and a question-
naire was mailed. Relatives of cases known to be deceased
at ascertainment were not contacted because of the need
to obtain detailed information concerning occupation
and occupational exposures including a variety of types of
pesticides. Control subjects were contacted directly by
mail. Living control subjects were eligible. Additional
methodological details have been previously published
[38].
Results
Information about the family history of cancer in first
degree relatives of 1528 cases: (HL (n = 316), MM (n =
342), NHL (n = 513), STS (n = 357)) and 1506 control
subjects was obtained. Descriptive characteristics of the
families studied are shown in Tables 1 through 4 [See
additional file 1: Table 1; additional file 2: Table 2; addi-
tional file 3: Table 3; additional file 4: Table 4]. The age
distribution, the mean age and standard deviation, the
number of first degree relatives, the mean number of sib-
lings and offspring, and the mean number of first degree
family members including parents among controls and
within each case group are shown in Table 1 [See addi-
tional file 1: Table 1]. HL cases were much younger com-
pared to MM, NHL, and STS cases. HL families were the
smallest with smaller mean number of siblings, sons and
daughters compared to families of other case groups and
controls. The four categories: small, medium, large and
largest categories were used to define the family size (for
definition see footnote under Table 2 [See additional file
2: Table 2]). There were distinctive differences in the fam-
ily size patterns (chi square = 61.5, df = 12, p < .0001)
across the case groups and controls, however the family
size patterns were not significantly different between STS
cases and controls (Table 2 [See additional file 2: Table 2],
chi square = 1.80, df = 3, p > 0.05). HL families were the
smallest. Families of HL, MM and STS were significantly
more likely to have had one affected generation than con-
trols, while a higher proportion of NHL families reported
two or more affected generations (Table 3 [See additional
file 3: Table 3]). A small minority of families reported
affected members in two or more generations. The distri-
bution of affected family members (chi-square = 59.8, df
= 8, p < .0001, the categories were zero, one, ≥ 2 affected
per family) and the percentage of families with two or
more affected individuals are presented in Table 4 [See
additional file 4: Table 4]. The majority of families were
cancer free, excluding the index subjects. A minority of
families included two or more affected first degree rela-
tives of the index subjects.
Table 5 [See additional file 5: Table 5] compares distribu-
tion of positive history of cancer in (i) at least one parent;
(ii) at least one sibling; and (iii) at least one child of each
case group with controls stratified by age distribution of
the index subject. Patterns of cancer prevalence are similar
among the index subjects diagnosed with four types of
cancer (HL, MM, NHL, and STS). The index subjects in the
age groups > 40, ≤49, and > 49, ≤59 had higher propor-
tion of at least one parent affected with cancer compared
to controls. The proportion of at least one sibling affected
with cancer increases with age of the index subject. The
siblings of older index subjects may be comparatively
older compared to the siblings of younger index subjects
and it is well known that risk of cancer increases with age.
In most of the age groups, index subjects have higher pro-
portion of at least one sibling affected with cancer com-
pared to controls. For the younger age groups (≤40, and >
40, ≤49), there was hardly any child affected with cancer,
because children of the index subjects in these age groups
may be younger and had very low risk of developing can-
cer. The proportions of at least one child affected with
cancer are small in the older age groups and among all
cases and controls.
Families ascertained through HL, MM, NHL, and STS
cases were compared to control families in Table 6 [See
additional file 6: Table 6]. Cases of HL [ORadj (95% CI
1.79 (1.33, 2.42)], MM [ORadj (95% CI 1.38 (1.07, 1.78)],
NHL [ORadj (95% CI 1.43 (1.15, 1.77)] and STS [1.30
(1.00, 1.68)] were more likely to have at least one first
degree relative diagnosed with cancer compared to con-
trols. Although the crude odds ratios (data not shown) for
several variables related to history of cancer among fami-
lies ascertained through HL cases were statistically non-
significant, adjustment for age and province of residence
produced statistically significant results due to theBMC Cancer 2009, 9:70 http://www.biomedcentral.com/1471-2407/9/70
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strength of the associations within certain strata. Index
subjects with at least one affected parent with a diagnosis
of cancer had increased risk of being diagnosed with HL
[1.57 (1.15, 2.14)]. This pattern did not appear in any of
the other case/control comparisons. HL [1.94 (1.12,
3.34)], MM [1.71 (1.22, 2.40)] and NHL [1.68 (1.23,
2.31)] cases were significantly more likely to have at least
one affected sibling than controls after adjustment for
total number of siblings. The excess of siblings was due to
more affected sisters among HL families [1.89 (1.05,
3.38)], MM families [1.66 (1.14, 2.40)] and NHL families
[1.52 (1.07, 2.17)]. Few children of index subjects (range
0.6% of HL families to 3.7% of MM families) had been
diagnosed with cancer.
Among each case/control family group, tumours of the
trachea, bronchus, lung (ICD-9 162) and of the female
breast (ICD-9 174) were first or second in frequency (data
not shown). The female to male ratio for tumours of the
trachea, bronchus, and lung was unexpectedly high;
1.45:1 for NHL relatives. There was also one male breast
cancer among NHL relatives. Among families of HL cases,
lymphoid leukaemia (ICD-9 204) and Hodgkin lym-
phoma (ICD-9 201) were third and fourth. Among fami-
lies of MM cases, colon (ICD-9 153) and prostate (ICD-9
185) tumours were third and fourth while stomach (ICD-
9 151) and lymphoid leukaemia occupied these ranks
among families of NHL cases. Lymphoid leukaemia and
liver cancer (ICD-9 155) tied for third place and rectum,
sigmoid junction and anus (ICD-9 154) was fourth in fre-
quency among STS families.
In this study, 54.4% of HL cases; 87.7% of MM cases;
79.7% of NHL cases; and 73.7% of STS cases reported to
have at least one child compared to 21.4% controls who
reported to have at least one child. The HL families
reported a higher frequency of birth defects than the con-
trol families although there did not appear to be a cluster-
ing of specific types (data is not shown). Cleft palate (n =
2) and pyloric stenosis (n = 2) were the only conditions to
occur in more than one family while Turner's syndrome,
hypospadia and atrophic testis each occurred in one HL
family.
Table 7 [See additional file 7: Table 7] displays certain
characteristics of the index subjects stratified by family
history of cancer. The variables include pesticide exposure
≥ 10 hours per year as a surrogate for occupational and
environmental pesticide exposure, cigarette smoking his-
tory (non-smokers, ex-smoker or current smoker) and age
at diagnosis. Comparisons of each case group with the
controls using mutually exclusive categories combining
family history status (positive, negative) with either pesti-
cide exposure ≥ 10 hours/year or lesser exposure indicated
that a positive family history (but not pesticide exposure)
was important for HL [(2.25 (1.61, 3.15)], that the com-
bination of pesticide exposure and a positive family his-
tory of cancer increased risk for MM [1.69 (1.14, 2.51)]
and that a positive family history of cancer both with
[1.72 (1.21, 2.45)] and without [1.43 (1.12, 1.83)] pesti-
cide exposure increased risk of NHL. A family history of
cancer both with [2.34 (1.57, 3.48)] and without [1.68
(1.01, 2.78)] a history of cigarette smoking increased risk
of HL. Cigarette smoking [1.46 (1.01, 2.12)] and family
history [1.73 (1.07, 2.80)] independently and in combi-
nation [1.79 (1.22, 2.63)] increased risk of MM while
only the combination of cigarette smoking and a positive
family history [1.45 (1.07, 1.96)] influenced risk of NHL.
There were no statistically significant results of compari-
sons of STS cases and controls.
Contrary to the expectation that those with a positive fam-
ily history of cancer will have experienced genetic and/or
environmental factors which might lower the age at diag-
nosis, HL, MM, and STS cases and the age at recruitment
of control subjects with a positive family history were sig-
nificantly older than those with a negative family history.
Discussion
Data from postal questionnaires based on responses from
513 NHL cases (67.1% of those contacted); 316 HL cases
(68.4% of those contacted); 342 MM cases (58.0% of
those contacted); 357 STS cases (60.8% of those con-
tacted); and 1506 controls (48.0% of those contacted)
were analyzed. Due to budget constraints, this study was
restricted to males. Previous studies [66,70-75] have dem-
onstrated that first degree family members are capable of
accuracy in reporting chronic illnesses such as cancer
among their immediate family members while accuracy
declines when the definition of family is expanded
[71,75]. Therefore, the study definition of family was
restricted to first degree relatives. We collected informa-
tion on (a) the number and the sex of siblings and chil-
dren, (b) the children of index subjects who had a genetic
disease, a birth defect or who were stillborn; and (c) rela-
tives, specifically on: the type of cancer, the relationship to
the index subjects, and the year and province of diagnosis
was collected. This comprehensive documentation per-
mitted us to consider family cancer history as stratified by
sex, by generation (parental, sibling, children) and by
multiple generations and to incorporate the total number
of siblings into the analyses.
Consistent with other studies of similar design [39-
41,53,66] with a range of 50% to 65% of cancer free fam-
ilies, we found that the majority of families were cancer-
free (excluding the index subjects). Previous studies [37-
54,66,70-73,75] have shown that the proportion of can-
cer free families varies with the type of index cancer, with
the manner in which the index subject is ascertained, withBMC Cancer 2009, 9:70 http://www.biomedcentral.com/1471-2407/9/70
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the age of the index subject and with the size of the family.
We found that HL families had the lowest (5.4%) and MM
families the highest (17.6%) percent of families with two
or more affected individuals per family compared to 8.3%
controls families with two or more affected per family.
An exploration of the generational pattern [2,3,30,49,66]
of cancer in affected relatives was useful in discussions
related to discriminating between inherited and environ-
mental factors contributing to a positive family history of
cancer. In our data and that of others as well, the genera-
tional patterns of cancer that emerged are parental only,
sibling only and multi-generational. A concentration of
tumours in one generation, whether parental or sibling,
might relate etiologically to time-dependent environmen-
tal exposures. In contrast, sibling clustering could also
relate to recessively inherited susceptibility. Additional
information on exposure to putative carcinogens, such as
tobacco smoke or specific pesticides, during the relevant
time periods aids in the assessment of the inherited/envi-
ronmental/interaction triad. In this study, statistically sig-
nificant increases in risk of at least one affected sibling of
the index subject were demonstrated for HL, MM and
NHL compared to control families. Among HL families,
there were also statistically significant increases in risk in
the parental generation (mother was affected, father was
unaffected and vice-versa, with; at least one affected par-
ent). This pattern of parental generation involvement was
not apparent for MM, NHL or STS families.
Ottman [76] summarized a variety of models illustrating
the potential modes of interaction among genetic and
environmental factors. By constructing mutually exclusive
categories that utilize the variables family history of can-
cer in combination with either exposure to pesticides > 10
hours per year or cigarette smoking, an examination of the
independent and combined effect of a personal character-
istic and environmental exposures to known or suspected
carcinogenic risk factors for these four types of tumours
was examined. Among HL index subjects, those with a
positive family history of cancer were at higher risk when
unexposed to pesticides while smoking status did not sub-
stantially influence the increased risk of HL conferred by a
positive family history. These patterns were consistent
with the genetic susceptibility etiological hypothesis [1,2]
related to HL. In the stratified analysis, the combination
of a positive family history and exposure to pesticides
increased risk of MM while neither variable did so inde-
pendently. In a cohort study [77], ex-smokers experienced
a three-fold risk of MM compared to life-time non-smok-
ers, with a dose-response effect. Positive histories of ciga-
rette smoking and family history independently and in
combination increased risk of MM without an apparent
dose effect in this study. This pattern suggests a lack of
synergism between the lifestyle factor, cigarette smoking
and the inherent factor, positive family history of cancer.
A positive family history of cancer both with and without
pesticide exposure increased risk of NHL suggesting that a
positive family history was more important than pesticide
exposure as defined in these analyses. Zahm et al [30]
reported that refining the definitions of family histories
from "any affected family member" to "affected first
degree relative with hemapoietic cancer", and pesticide
exposure (i.e. from residence on a farm to personal appli-
cation of a specific chemical class of insecticide) resulted
in a dose response pattern among women. The relation-
ship of cigarette smoking to risk of NHL is controversial
and smoking risk may only be related to specific subtypes
of NHL. In this study, only the combination of cigarette
smoking and positive family history significantly influ-
enced risk of NHL, although the odds ratios and 95% con-
fidence intervals for the combinations of positive family
history with non smokers and ever smokers were similar.
Linet et al [78] reported that only the combination of pos-
itive family history and cigarette smoking increased risk of
NHL.
The major limitation of this study is the fact that the fam-
ily history of cancer was obtained by report from the index
subjects and these reports were not validated by reference
to the appropriate provincial cancer registries. There are
difficulties involved in validation of self-reported family
history of cancer by index subjects as reported by other
authors [66,79].
Our study has the advantages of recruiting incident cases
and controls from population-based sources covering a
large geographical area of Canada. There were three to five
controls for each case which increased the statistical
power of the study. The use of a common control group
and identical methodology permitted comparisons of the
importance of a family history of cancer among the four
types of cancer studied.
If a familial aggregation of cancer is a surrogate for an
inherited, genetic etiology, certain predictions apply
[2,66] and we have evaluated our data with respect to sev-
eral of these. The predictions include: 1. a younger age at
diagnosis among those with a positive family history of
cancer compared to the general population or those with
a negative family history. Our data demonstrated a signif-
icantly older age at diagnosis among those with a positive
family history for each cancer group and the controls com-
pared to those with a negative family history. Previously,
Schneider et al [80] demonstrated familial clustering of
cancer among relatives of randomly selected cancer cases
without regard to age of the index subject. 2. A multigen-
erational pattern of tumours occurring in both sexes is of
interest because the inherited, genetic hypothesis predicts
that at least one of the precancerous steps occurred prena-BMC Cancer 2009, 9:70 http://www.biomedcentral.com/1471-2407/9/70
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tally and each cell within the body therefore has a height-
ened susceptibility. The predicted pattern was strongest
for HL families followed by NHL and MM families. The
predicted pattern was not found among STS families. 3.
The potential role of environmental factors is complex as
specific exposures may act as tumour initiators, or as
agents influencing progression or promotion of tumour
growth. In the stratified analyses exploring the contribu-
tions of pesticide exposure or cigarette smoking inde-
pendently and in combination with a positive family
history of cancer, we did not find strong evidence of syn-
ergism in those with combined exposure.
Conclusion
HL, MM, NHL, and STS cases had higher incidence of can-
cer if any first degree relative affected with cancer com-
pared to control families. A positive family history of
cancer and/or shared environmental exposure to agricul-
tural chemicals play an important role in the develop-
ment of cancer.
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